Key result
The caffeine-halothane contracture test achieved a sensitivity of 97% (95% CI, 84-100%) and a specificity of 78% (95% CI, 69-85%) for diagnosing malignant hyperthermia susceptibility.
Why the study?
What is the sensitivity and specificity of the caffeine-halothane contracture test for diagnosing malignant hyperthermia susceptibility?
Population
152 subjects from the North American Malignant Hyperthermia Registry database, comprising 32 case subjects…
Design
Case-control
Authors
Loading...
CHCT supports diagnostic use in suspected MH; leaves open prospective validation of thresholds in broader populations.
Case-Control (n=152)
Yes
What is the sensitivity and specificity of the caffeine-halothane contracture test for diagnosing malignant hyperthermia susceptibility?
Absolute Event Rate: 97% vs 78%
The caffeine-halothane contracture test demonstrates high sensitivity and acceptable specificity for diagnosing malignant hyperthermia susceptibility, though it is not suitable for general population screening.
Allen et al. (1998) conducted a case-control in Malignant hyperthermia (n=152). Caffeine-halothane contracture test (CHCT) vs. Low-risk controls was evaluated on Sensitivity and specificity of the CHCT (95% CI 84-100). The caffeine-halothane contracture test achieved a sensitivity of 97% (95% CI, 84-100%) and a specificity of 78% (95% CI, 69-85%) for diagnosing malignant hyperthermia susceptibility.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: